252 related articles for article (PubMed ID: 17123690)
1. Second trimester amniotic fluid endothelin-1 concentrations and subsequent development of intrauterine growth restriction.
Margarit L; Griffiths AN; Tsapanos V; Tsakas S; Gumenos D; Decavalas G
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):192-5. PubMed ID: 17123690
[TBL] [Abstract][Full Text] [Related]
2. Second trimester amniotic fluid endothelin concentration. A possible predictor for pre-eclampsia.
Margarit L; Griffiths A; Tsapanos V; Decavalas G; Gumenos D
J Obstet Gynaecol; 2005 Jan; 25(1):18-20. PubMed ID: 16147686
[TBL] [Abstract][Full Text] [Related]
3. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
[TBL] [Abstract][Full Text] [Related]
4. Second trimester amniotic fluid annexin A5 levels and subsequent development of intrauterine growth restriction.
Dundar O; Yoruk P; Tutuncu L; Muhcu M; Ipcioglu O; Ergur AR; Mungen E
Prenat Diagn; 2008 Oct; 28(10):887-91. PubMed ID: 18792921
[TBL] [Abstract][Full Text] [Related]
5. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
6. Annexin A5 levels in midtrimester amniotic fluid: association with intrauterine growth restriction.
Van Eerden P; Wu XX; Chazotte C; Rand JH
Am J Obstet Gynecol; 2006 May; 194(5):1371-6. PubMed ID: 16579937
[TBL] [Abstract][Full Text] [Related]
7. Amniotic fluid endothelin levels and the incidence of premature rupture of membranes.
Margarit L; Griffiths AN; Tsapanos V; Tsakas S; Decavalas G
Int J Gynaecol Obstet; 2006 Apr; 93(1):18-21. PubMed ID: 16434046
[TBL] [Abstract][Full Text] [Related]
8. Fetal erythropoietin and endothelin-1: relation to hypoxia and intrauterine growth retardation.
Ostlund E; Lindholm H; Hemsen A; Fried G
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):276-82. PubMed ID: 10746842
[TBL] [Abstract][Full Text] [Related]
9. Elevated mid-trimester amniotic fluid ADAM-8 concentrations as a potential risk factor for preterm delivery.
Vrachnis N; Malamitsi-Puchner A; Samoli E; Botsis D; Iliodromiti Z; Baka S; Hassiakos D; Creatsas G
J Soc Gynecol Investig; 2006 Apr; 13(3):186-90. PubMed ID: 16638589
[TBL] [Abstract][Full Text] [Related]
10. Amniotic fluid epidermal growth factor levels in normal and abnormal pregnancies.
Varner MW; Dildy GA; Hunter C; Dudley DJ; Clark SL; Mitchell MD
J Soc Gynecol Investig; 1996; 3(1):17-9. PubMed ID: 8796801
[TBL] [Abstract][Full Text] [Related]
11. [Study on the relationship between epidermal growth factor and fetal growth retardation].
Dong M; He J; Wang Z
Zhonghua Fu Chan Ke Za Zhi; 1999 Mar; 34(3):135-7. PubMed ID: 11263179
[TBL] [Abstract][Full Text] [Related]
12. ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR.
Baviera G; D'Anna R; Corrado F; Ruello A; Buemi M; Jasonni VM
J Reprod Med; 2002 Mar; 47(3):191-3. PubMed ID: 11933682
[TBL] [Abstract][Full Text] [Related]
13. Amniotic levels of nitric oxide in women with fetal intrauterine growth restriction.
Tranquilli AL; Bezzeccheri V; Giannubilo SR; Scagnoli C; Mazzanti L; Garzetti GG
J Matern Fetal Neonatal Med; 2003 Feb; 13(2):115-8. PubMed ID: 12735412
[TBL] [Abstract][Full Text] [Related]
14. Increasing amniotic fluid magnesium concentrations with stable maternal serum levels: a prospective clinical trial.
Gortzak-Uzan L; Mezad D; Smolin A; Friger M; Huleihel M; Hallak M
J Reprod Med; 2005 Nov; 50(11):817-20. PubMed ID: 16419627
[TBL] [Abstract][Full Text] [Related]
15. Amniotic fluid endothelin-1 levels are increased in pregnancy-induced hypertension and intrauterine growth retardation.
Di Iorio R; Marinoni E; Anceschi MM; Emiliani S; Letizia C; Cosmi EV
Am J Reprod Immunol; 1996 Nov; 36(5):260-3. PubMed ID: 8955502
[TBL] [Abstract][Full Text] [Related]
16. Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction.
Murisier-Petetin G; Gremlich S; Damnon F; Reymondin D; Hohlfeld P; Gerber S
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):15-20. PubMed ID: 19217707
[TBL] [Abstract][Full Text] [Related]
17. Elevated second trimester amniotic fluid interferon gamma-inducible T-cell alpha chemoattractant concentrations as a possible predictor of preterm birth.
Malamitsi-Puchner A; Vrachnis N; Samoli E; Baka S; Hassiakos D; Creatsas G
J Soc Gynecol Investig; 2006 Jan; 13(1):25-9. PubMed ID: 16378910
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function.
Fasshauer M; Blüher M; Stumvoll M; Tönessen P; Faber R; Stepan H
Clin Endocrinol (Oxf); 2007 Mar; 66(3):434-9. PubMed ID: 17302880
[TBL] [Abstract][Full Text] [Related]
19. [Study on the relationship between perinatal hypoxia and concentration of endothelin-1 in amniotic fluid].
Xu L; Liu P; Yan D
Zhonghua Fu Chan Ke Za Zhi; 1999 Oct; 34(10):591-3. PubMed ID: 11477795
[TBL] [Abstract][Full Text] [Related]
20. Clara cell protein 16 concentration in mid-trimester amniotic fluid: association with fetal gender, fetal G>A +38 CC16 gene polymorphism and pregnancy outcome.
Perni SC; Vardhana S; Kalish R; Chasen S; Witkin SS
J Reprod Immunol; 2005 Dec; 68(1-2):85-90. PubMed ID: 16236364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
